Overview
Nadezda Lipunova practices practicing medicine in Oxford, United Kingdom.
Their clinical expertise encompasses Bladder Cancer, Childhood Acute Myeloid Leukemia, and Essential Thrombocythemia.
They are actively involved in clinical research, co-authoring 9 peer reviewed articles.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Frequently Asked Questions about Nadezda Lipunova
Is Nadezda Lipunova a top-rated expert for Bladder Cancer?
MediFind is an objective health platform that identifies experts based on real-world data. Nadezda Lipunova is classified as an Experienced expert for Bladder Cancer, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
Does Nadezda Lipunova participate in research or clinical trials?
Yes. Nadezda Lipunova has published 9 articles and abstracts on conditions like Bladder Cancer. You can view a list of Nadezda Lipunova's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Experienced
- Bladder CancerLipunova isExperienced. Learn about Bladder Cancer.
- Childhood Acute Myeloid LeukemiaLipunova isExperienced. Learn about Childhood Acute Myeloid Leukemia.
- Essential ThrombocythemiaLipunova isExperienced. Learn about Essential Thrombocythemia.